Point72 Middle East FZE’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-22,987
Closed -$34.5K 1287
2023
Q1
$34.5K Buy
+22,987
New +$34.5K ﹤0.01% 792